clinical trial · NCT07553728
Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
Changchun GeneScience Pharmaceutical Co., Ltd.·—·not yet recruiting·n = 200
InfertilityNA，Observational study
brief summary
This is a multi-centre, single-arm, observational trial to assess the safety and efficacy of corifollitropin alfa N02 Injection in elderly Chinese women undergoing ART, and then to explore the compliance and satisfaction during COS treatment.
started
May 1, 2026
primary completion
Aug 4, 2029
completion
Dec 16, 2029
last updated
Apr 28, 2026
official title
A Multi-center, Single-arm, Observational Study to Assess the Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol